Cardiac sarcoidosis: A long term follow up study.
Patrice CacoubCatherine Chapelon-AbricMatthieu Resche-RigonDavid SaadounAnne Claire DesboisLucie BiardPublished in: PloS one (2020)
Our study identifies putative factors affecting morbidity and mortality in cardiac sarcoidosis patients. Intravenous cyclophosphamide is associated with lower relapse rates.